These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6295997)

  • 1. Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime.
    Cable D; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():121-7. PubMed ID: 6295997
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of bacterial meningitis with ceftizoxime.
    Overturf GD; Cable DC; Forthal DN; Shikuma C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):258-62. PubMed ID: 6324670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)].
    Ruf B
    Infection; 1982; 10(2):76-80. PubMed ID: 6284650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
    Friedland IR; Klugman KP
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1888-91. PubMed ID: 9303379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of purulent meningitis with ceftriaxone].
    Guggenbichler JP; Parth J
    Wien Med Wochenschr Suppl; 1985; 87():12-6. PubMed ID: 3856970
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis].
    Stahl JP; Croize J; Bru JP; Pegourie B; Blanc-Jouvan F; Bryskier A; Micoud M
    Pathol Biol (Paris); 1985 May; 33(5):365-7. PubMed ID: 3897967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and clinical effects of ceftizoxime in pediatric field (author's transl)].
    Jpn J Antibiot; 1982 Jan; 35(1):113-36. PubMed ID: 6279904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
    Chandrasekar PH; Rolston KV; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1984 Oct; 14(4):427-30. PubMed ID: 6094424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical studies in pediatric field on ceftizoxime (author's transl)].
    Nakazawa S; Sato H; Nakazawa SI; Niino K; Hirama Y; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1982 Jan; 35(1):33-46. PubMed ID: 6279912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of ceftriaxone in blood and ventricular cerebrospinal fluid in children with ventriculitis].
    Prado V; Arancibia A; Aguirre X
    Bol Med Hosp Infant Mex; 1984 Jun; 41(6):313-7. PubMed ID: 6089848
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of ceftriaxone with standard therapy for bacterial meningitis.
    Steele RW; Bradsher RW
    J Pediatr; 1983 Jul; 103(1):138-41. PubMed ID: 6306192
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P; Floret D; Mallet E; Raynaud EJ; Safran C; Sarlangues J; Teyssier G
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-blind controlled study of ceftizoxime and cefamandole in the treatment of community-acquired pneumonia.
    Grieco MM; Lange M; Daniels JA; Den M; Amaram N; Kornfeld H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():223-5. PubMed ID: 6296010
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with ceftizoxime: an overall summary of clinical trials in Japan.
    Shimada J; Shimizu K
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():311-26. PubMed ID: 6296026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.